Antibody data
- Antibody Data
- Antigen structure
- References [4]
- Comments [0]
- Validations
- Immunohistochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN306839 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Neuregulin 1 (NRG1) antibody
- Antibody type
- Monoclonal
- Antigen
- Other
- Reactivity
- Human, Mouse, Rat
- Host
- Mouse
- Isotype
- IgG
- Antibody clone number
- 7D5
- Vial size
- 100 μg
- Concentration
- 1 mg/ml
- Storage
- -20°C
Submitted references Hyperactive autocrine loop mediated by a NDF-related factor in neoplastic hamster embryo fibroblasts expressing an activated cph oncogene.
Identification of heregulin, a specific activator of p185erbB2.
Neu differentiation factor: a transmembrane glycoprotein containing an EGF domain and an immunoglobulin homology unit.
Isolation of the neu/HER-2 stimulatory ligand: a 44 kd glycoprotein that induces differentiation of mammary tumor cells.
Avila MA, Velasco JA, Cho C, Lupu R, Wen D, Notario V
Oncogene 1995 Mar 2;10(5):963-71
Oncogene 1995 Mar 2;10(5):963-71
Identification of heregulin, a specific activator of p185erbB2.
Holmes WE, Sliwkowski MX, Akita RW, Henzel WJ, Lee J, Park JW, Yansura D, Abadi N, Raab H, Lewis GD
Science (New York, N.Y.) 1992 May 22;256(5060):1205-10
Science (New York, N.Y.) 1992 May 22;256(5060):1205-10
Neu differentiation factor: a transmembrane glycoprotein containing an EGF domain and an immunoglobulin homology unit.
Wen D, Peles E, Cupples R, Suggs SV, Bacus SS, Luo Y, Trail G, Hu S, Silbiger SM, Levy RB
Cell 1992 May 1;69(3):559-72
Cell 1992 May 1;69(3):559-72
Isolation of the neu/HER-2 stimulatory ligand: a 44 kd glycoprotein that induces differentiation of mammary tumor cells.
Peles E, Bacus SS, Koski RA, Lu HS, Wen D, Ogden SG, Levy RB, Yarden Y
Cell 1992 Apr 3;69(1):205-16
Cell 1992 Apr 3;69(1):205-16
No comments: Submit comment
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- Immunohistochemical staining using HRG antibody on formalin fixed, paraffin embedded human prostate carcinoma tissue sections.